Jiménez Rodríguez, Begoña

Speciality

Medical Oncology. Breast Cancer

Registration No.

29/29/09900

Languages

Spanish, English.

Training

2007 Bachelor of Medicine and Surgery, University of Málaga.
 
2011 Official Doctoral Programme in Medicine. Research Proficiency from the University of Malaga.
 
2022: Masters in Molecular Oncology. King Juan Carlos University. Madrid
 

Other courses

2021: Course in Gynaecological Oncology. Spanish Ovarian Cancer Research Group.
 
2021: Course in Molecular Diagnosis in Breast Cancer. Meeting campus.
 
2016: Ovarian Cancer Refresher Programme. Spanish Ovarian Cancer Research Group.
 
Co-investigator in National and International Clinical Trials at Hospital Virgen de la Victoria. Malaga.
 
Principal Co-investigator in “First-in-human” Clinical Trials at The Royal Marsden Hospital and Institute of Cancer Research.

Employment History

Currently: Medical oncologist specialising in the breast at HC Marbella
 
April 2015- 2022: Medical Oncology breast specialist at Hospital Virgen de la Victoria. Málaga.
 
May 2013 – December 2014. Clinical Research Fellow at The Royal Marsden Hospital and The Institute of Cancer Research.
 
June 2012 – March 2013. Medical oncologist in the Andalusian Health Service at the HCU Virgen de la Victoria, Malaga.
 
May 2008 – May 2012. She completed her residency in Medical Oncology at HCU Virgen de la Victoria, Malaga.
 

Scientific Activity

2020 -2024:Investigator in the project “The role of breast and intestinal microbiota in the different intrinsic subtypes of breast cancer and in its response to treatment”. ANDALUSIAN PUBLIC FOUNDATION FOR HEALTH AND BIOMEDICINE RESEARCH IN MÁLAGA (FIMABIS).
 
2020 – 2023: Investigator in the project “Liquid biopsy in the multi-somal use of circulating tumour components: Characterization of the risk of relapse and detection of minimal residual disease in patients with early breast cancer”. Hospital Clinico Universitario Virgen La Victoria -CIMES.
 
2017 – 2018: Researcher in the project “Analysis of ctDNA as a method of early breast cancer detection.” FSEOM-Font Vella. Andalusian Public Foundation for Health and Biomedicine Research in Malaga.
 
2017: FSEOM-Rio Hortega Fellowship-Contract. SEOM (Spanish Society of Medical Oncology) – Carlos III Health Institute.
 
2013:Training Fellowship in Clinical Research in Reference Centres Abroad. Spanish Society of Medical Oncology and The Royal Marsden Hospital and The Institute of Cancer Research. London.
 
2013:: Fellowship at The Royal Marsden Hospital and The Institute of Cancer Research. In “Drug Development Unit (Phase I clinical Trials Unit).”

Publications

She has participated in various publications and attended several national and international congresses in Medical Oncology.
 
Author of numerous scientific Medical Oncology publications in journals and book chapters, nationally and internationally.
 
Some of her publications:
 

Begoña Jiménez Rodríguez; Gema Díaz Córdoba; Alicia Garrido Aranda; Luis Vicioso Recio; Rosario Chica Parrado; Vanessa DeLuque; Maria Jose Lozano; Maria del Mar Moreno Ros; Estefania Bellagarza; Cristina Hernando; Begoña Bermejo; Ana Lluch; Martina Álvarez; Emilio Alba. “Plasma sequencing of ctDNA in early stage breast cancer as part of the screening process.”

 

Begoña Jimenez Rodriguez; Ana Isabel Lavado; Nuria Ribelles; Pedro Sacnhez-Rovira; Luis Vicioso; Martina Alavarez; Vanessa deLuque; Cesar Ramirez; Wesley Buckingham; Carl Schaper; Arthur Jeiranian; Naeem Dowidar; Ester Villar; Sean Ferree; Irene Zarcos; Alfonso Sanchez-Muñoz; Carlos Gonzalez-Hermoso; Casilda Llacer; Aleix Prat; Emilio Alba. “Prosigna (PAM50) to predict response to neoadjuvant chemotherapy (NAC) in HR+/HER2- early breast cancer (EBC) patients.”

 

BEGOÑA JIMENEZ RODRIGUEZ; Gema Diaz Córdoba; Alicia garrido Aranda; Martina Álvarez; Luis Vicioso; Casilda Llácer Pérez; Cristina Hernando; BEgoña Bermejo; A J Parreño; Ana Lluch; Mathew Ryder; Frederic Jones; Johannes Fredebohm; Frak Holtrup; M Isabel Queipo-Ortuño; Emilio Alba. Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis.Journal of Clinical Medicine 2019, 8, 1183; doi:10.3390/jcm8081183. 8(8):1183 – doi:10.3390/jcm8081, 07/08/2019.

 

BEGOÑA JIMENEZ RODRIGUEZ; Caroline Michie; David Lorente; Hasina Hassam; Helen Toloui; Jimena Lovos; Debarati Goswami; Johann de Bono; Udai Banerji; Stan Kaye; L Rhoda Molife. “Long-term survivors in phase I clinical trials: who are they and what predicts their survival?”.

 

BEGOÑA JIMENEZ RODRIGUEZ; Jose M Trigo Pérez; Maria I Sáez Medina; Cristina Quero Blanco; Bella Isabel Pajares Hachero; Víctor Navarro Pérez; Casilda Llácer Pérez; Laura Medina Rodríguez; Emilio Alba Conejo. “Eficacia y seguridad de paclitaxel en combinación con cetuximab en el tratamiento de pacientes con cáncer de cabeza y cuello recidivado o metastásico previamente tratados”.

Member Of:

– ESMO (European Society of Medical Oncology)
– SEOM (Spanish Society of Medical Oncology)
– SAOM (Andalusian Society of Medical Oncology)
– GEICAM (Spanish Breast Cancer Research Group)
– GEICO (Spanish Ovarian Cancer Research Group)